Protein Engineering Congress Global 2022

Protein Engineering: Bringing forward the latest innovations in protein engineering to drive more valuable intermediates for industrial applications

Silicon Valley
15-16 October, 2022

“A very specific and engaging meeting that brings together both enzyme engineering providers and end-users”

Zymvol

Why Attend

With the emergence of new techniques and methods to reconstruct and engineer enzymes, it is more exciting than ever to be working in protein engineering. Avoid missing out and join 20+ industry-leading speakers from Merck, BASF, Microsoft, Pfizer, and more as they discuss the biggest hurdles in driving more sustainable, selective, and valuable processes. 

The series brings together a global audience and global lineup of biocatalyst and protein modifications specialists to share how to implement the new technologies. With the applications growing across pharmaceutical, flavour & fragrance, consumer goods, food & beverage and agrochemical sectors, we have created a protein and enzyme engineering platform that will allow the community to improve capabilities to industrialize sustainable enzyme products and increase product efficiency globally.

  1. Understand the challenges and requirements of the industry in their internal R&D projects to support scale-up processes, next-generation mutant library screening, or knowledge of machine learning and AI to optimize biocatalysts for industrial applications.
  2. Expand your commercial opportunities and market growth by learning what new industry sectors are seeing the benefit of enzyme engineering to synthesize unprecedented molecules of interest and engage and network with these industries to form new third-party collaborations, allowing you to advance your market growth.
  3. Demonstrate advancements in your service capabilities by actively promoting the work of your technical teams through bespoke webinar opportunities, presentations, and interactive discussion with the industry.
  4. Though we’re aiming for a face-to-face event, if you’re unable to join us in San Jose, replicate that ‘chance meeting’ at our networking roulette and take advantage of our 1-2-1 networking platform to facilitate new connections that lead to a great ROI.

 

30+
Leading speakers
130+
Delegates

Attendees

40%
Industry
23%
Academics
20%
PhD Students
9%
Biotechs
8%
Service Providers

Industry

Academics

PhD Students

Biotechs

Service Providers

2021 SPEAKERS

 

Claes Gustafsson

CCO, Co-Founder
ATUM

Claes Gustafsson

CCO, Co-Founder
ATUM

Claes Gustafsson

CCO, Co-Founder
ATUM
 

Debora Marks

Associate Professor of Systems Biology
Harvard Medical School

Debora Marks

Associate Professor of Systems Biology
Harvard Medical School

Debora Marks

Associate Professor of Systems Biology
Harvard Medical School
 

Emily Wrenbeck

Head of Protein Engineering
Ginkgo Bioworks

Emily Wrenbeck

Head of Protein Engineering
Ginkgo Bioworks

Emily Wrenbeck

Head of Protein Engineering
Ginkgo Bioworks
 

Gregory Stephanopoulos

MIT

Gregory Stephanopoulos

MIT

Gregory Stephanopoulos

MIT
 

Huimin Zhao

Professor – Chemical and Biomolecular Engineering
University of Illinois

Huimin Zhao

Professor – Chemical and Biomolecular Engineering
University of Illinois

Huimin Zhao

Professor – Chemical and Biomolecular Engineering
University of Illinois
 

Jeremy Steflik

Senior Scientist, Process Development
Pfizer, Inc

Jeremy Steflik

Senior Scientist, Process Development
Pfizer, Inc

Jeremy Steflik

Senior Scientist, Process Development
Pfizer, Inc
 

Justin English

Assistant Professor – Biochemistry
University of Utah

Justin English

Assistant Professor – Biochemistry
University of Utah

Justin English

Assistant Professor – Biochemistry
University of Utah
 

Justin Siegel

Associate Professor, Department of Chemistry
UC Davis

Justin Siegel

Associate Professor, Department of Chemistry
UC Davis

Justin Siegel

Associate Professor, Department of Chemistry
UC Davis
 

Kevin Yang

Senior Researcher
Microsoft

Kevin Yang

Senior Researcher
Microsoft

Kevin Yang

Senior Researcher
Microsoft
 

Maria Lucas

CEO
Zymvol

Maria Lucas

CEO
Zymvol

Maria Lucas

CEO
Zymvol
 

Pierre Gilles

Project Manager
Protéus by Seqens

Pierre Gilles

Project Manager
Protéus by Seqens

Pierre Gilles

Project Manager
Protéus by Seqens
 

Toni Lee

Director of Enzymology
Solugen

Toni Lee

Director of Enzymology
Solugen

Toni Lee

Director of Enzymology
Solugen
 

Tyler Korman

Director of R&D
Invizyne

Tyler Korman

Director of R&D
Invizyne

Tyler Korman

Director of R&D
Invizyne
 

Karim Beguir

Co-Founder & CEO
InstaDeep

Karim Beguir is the chief executive officer and co-founder of InstaDeep.

He helps companies come to grips with the latest AI breakthroughs and deploy them to improve efficiency and ROI.

As a graduate of France's Ecole Polytechnique and former program fellow at New York University's Courant Institute, Karim has a passion for teaching and using applied mathematics. He's also a Google developer expert and a mentor at Google for Startups Accelerator, and is a steering committee member of Deep Learning Indaba.

Karim Beguir

Co-Founder & CEO
InstaDeep

Karim Beguir

Co-Founder & CEO
InstaDeep

Karim Beguir is the chief executive officer and co-founder of InstaDeep.

He helps companies come to grips with the latest AI breakthroughs and deploy them to improve efficiency and ROI.

As a graduate of France's Ecole Polytechnique and former program fellow at New York University's Courant Institute, Karim has a passion for teaching and using applied mathematics. He's also a Google developer expert and a mentor at Google for Startups Accelerator, and is a steering committee member of Deep Learning Indaba.

Karim is on a mission to democratize AI and make it accessible to a wide audience.

 

 

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.

After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.

John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist. 

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

John McIntosh

Biocatalytic synthesis of nucleotide therapeutics
Merck

For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.

After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.

John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist. 

 

Adrienne Davenport

Director of Research-Enzyme Discovery and Screening
BASF

Adrienne Davenport

Director of Research-Enzyme Discovery and Screening
BASF

Adrienne Davenport

Director of Research-Enzyme Discovery and Screening
BASF
 

Ryan Phelan

Sr. Scientist II - Biocatalysis (Process Chem/Catalysis Group)
AbbVie

Ryan Phelan

Sr. Scientist II - Biocatalysis (Process Chem/Catalysis Group)
AbbVie

Ryan Phelan

Sr. Scientist II - Biocatalysis (Process Chem/Catalysis Group)
AbbVie
 

Katharina Neufeld

Senior Researcher, Biocatalysis
Janssen

Katharina Neufeld

Senior Researcher, Biocatalysis
Janssen

Katharina Neufeld

Senior Researcher, Biocatalysis
Janssen
 

Jill Caswell

Biology Team Leader
Almac

Dr. Jill Caswell is the Biology Team Leader within Almac’s Biocatalysis group. After obtaining a degree in Biochemistry Jill worked in the industry producing recombinant proteins in a variety of host organisms before obtaining a PhD in 2011 through an industrial collaboration with Queen’s University Belfast.

 

Jill Caswell

Biology Team Leader
Almac

Jill Caswell

Biology Team Leader
Almac

Dr. Jill Caswell is the Biology Team Leader within Almac’s Biocatalysis group. After obtaining a degree in Biochemistry Jill worked in the industry producing recombinant proteins in a variety of host organisms before obtaining a PhD in 2011 through an industrial collaboration with Queen’s University Belfast.

 

Jill’s career has focussed on recombinant enzyme expression as well as molecular biology techniques that enable enzyme engineering. She joined Almac’s Biocatalysis group in 2012 with 10 years of industry-relevant experience to bring to the biology team, helping to grow the enzyme engineering capabilities.

 

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel is a scientist-entrepreneur focused on applied genomics and synthetic biology. Authored key patents, publications and book chapters in synthetic biology and genomics. Founded and secured $15.3M in funding for two biotech start-up companies.

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel, PhD

CEO
Loop Genomics

Tuval Ben-Yehezkel is a scientist-entrepreneur focused on applied genomics and synthetic biology. Authored key patents, publications and book chapters in synthetic biology and genomics. Founded and secured $15.3M in funding for two biotech start-up companies.

EVENT SCHEDULE

Find out who is speaking and joining Protein Engineering Global USA, taking place online.

Please fill out the short form to access the 2021 event schedule.

The speaker lineup this year is not to be missed, we will be joined by 20+ industry leaders such as...

PE USA

and more! This year, be prepared to...

  • Incorporate machine learning developments in computational biology, AI and deep learning within protein engineering with Microsoft’s Kevin Yang
  • Create carbon negative, environmentally friendly chemicals with uncompromised performance with Toni Lee, Director of Enzymology, Solugen
  • Engineer the fermentation yeast saccharomyces cerevisiae for the renewable production of industrial biocommodities with MIT's Gregory Stephanopoulos
  • Evaluate how to automate and scale the process of organism engineering to prototype thousands of biological designs with Emily Wrenbeck, Gingko Bioworks
  • Hear from John McIntosh, Merck, to establish approaches for biocatalytic synthesis of nucleotide therapeutics
  • Consolidate your protein engineering techniques to drive innovation in process development with Jeremy Steflik, Pfizer
  • Learn the latest industrial applications of protein engineering with Merck, Zymvol, BASF and more, to take advantage of crucial technology integration from across sectors

Will you be joining us?

PE USA

Download 2021 agenda

JOIN THE COMMUNITY

Platinum Partner

Gold Partners

Expertise Partners

Event Partners

2021 Media Partners

Become a Partner

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Resources

Download Resource

Contact Us

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.